Which antihistamines should be avoided in patients with arrhythmia, including those with congenital long‑QT syndrome or on other QT‑prolonging drugs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antihistamines to Avoid in Arrhythmia

Avoid terfenadine, astemizole, diphenhydramine, orphenadrine, and hydroxyzine in patients with arrhythmias or prolonged QT interval, as these agents can cause fatal ventricular arrhythmias including torsades de pointes. 1, 2

High-Risk Antihistamines (Contraindicated)

The following antihistamines are specifically contraindicated due to documented QT prolongation and arrhythmogenic potential:

Withdrawn from Market

  • Terfenadine - Blocks cardiac K+ channels (hERG/IKr), causes QT prolongation and torsades de pointes 2, 3
  • Astemizole - Similar mechanism to terfenadine, associated with fatal arrhythmias 2, 4

Still Available (Avoid in Arrhythmia)

  • Diphenhydramine - Contraindicated in long QT syndrome 1
  • Orphenadrine - Contraindicated in long QT syndrome 1
  • Hydroxyzine - Contraindicated in long QT syndrome 1

Safe Alternatives

The following second-generation antihistamines have NOT been associated with QT prolongation or torsades de pointes and can be used with caution:

  • Fexofenadine - No electrocardiographic effects even at supratherapeutic doses 1, 2
  • Loratadine/Desloratadine - Does not inhibit cardiac K+ channels at therapeutic levels 1, 2
  • Cetirizine/Levocetirizine - No QT effects documented 1, 2
  • Ebastine - No published QT effects 1
  • Azelastine - No electrocardiographic effects 2

Critical Risk Factors to Assess

When prescribing any antihistamine to patients with arrhythmia concerns, evaluate these specific factors per the 2023 Canadian Cardiovascular Society guidelines 5:

Patient-Specific Risks

  • QTc ≥500 ms - Highest risk threshold for torsades de pointes 5
  • Female sex - Higher risk for acquired long QT syndrome 5
  • Elderly patients - Increased susceptibility 5
  • Structural heart disease - Elevates risk 5

Medication Interactions

Critical drug combinations that dramatically increase risk:

  • Macrolide antibiotics (erythromycin > azithromycin) with antihistamines 5, 4
  • Imidazole antifungals (ketoconazole, itraconazole) - inhibit hepatic metabolism 4
  • Concurrent use of other QT-prolonging drugs 5

Metabolic Factors

  • Hypokalemia - Especially with concurrent diuretic use 5
  • Hypomagnesemia - Monitor closely 5
  • Hepatic insufficiency - Prevents metabolism of terfenadine/astemizole 2
  • Renal impairment - May require dose adjustments 5

Practical Management Algorithm

  1. Check baseline QTc if patient has known arrhythmia, congenital long QT, or is on other QT-prolonging drugs 5

  2. Verify drug interactions using www.crediblemeds.org before prescribing 5

  3. Select from safe alternatives (fexofenadine, loratadine, cetirizine, levocetirizine) 1, 2

  4. Avoid combining antihistamines with macrolides or azole antifungals - choose alternative antibiotics (penicillins, cephalosporins) instead 5

  5. Monitor electrolytes if patient is on diuretics or has renal dysfunction 5

  6. Do NOT use if QTc >500 ms or if QTc increases by >60-70 ms from baseline 5

Key Mechanistic Understanding

The dangerous antihistamines block the hERG potassium channel (IKr current), which delays ventricular repolarization and prolongs the QT interval 3. This creates the substrate for early afterdepolarizations and dispersion of repolarization, triggering torsades de pointes through a re-entry mechanism 3, 6. The safer second-generation agents do not significantly inhibit these cardiac channels at clinically achievable blood levels 2.

Common Pitfall

The most dangerous scenario is combining an antihistamine with drugs that inhibit hepatic metabolism (macrolides, azole antifungals), which causes accumulation to toxic levels even at normal doses 4. This is how most fatalities occurred with terfenadine and astemizole. Always check for these interactions before prescribing, even with "safer" antihistamines.

References

Research

Arrhythmogenic mechanisms of non-sedating antihistamines.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1999

Research

Cardiovascular toxicity of antihistamines.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1994

Research

Torsade de pointes.

Clinical cardiology, 1993

Related Questions

Is cetirizine safe for patients with long QT syndrome?
In a patient with a QTc of 531 ms who is only taking nebivolol, can nebivolol be responsible for the prolonged QT interval, and is it safe to start an ACE inhibitor or a thiazide diuretic?
Is carbetocin safe for use in patients with long QT syndrome (LQTS)?
How should chlorpromazine (Largartil)–induced prolonged QT interval be managed, and how to treat the risk of severe toxicity leading to deep coma?
How should a prolonged QT interval be treated?
Is migraine a contraindication for deep transcranial magnetic stimulation (deep TMS)?
Is the provided impression and management plan appropriate for a 32-year-old female presenting for an annual physical with acute viral upper respiratory infection (dry cough, sinus congestion, headache), anxiety refractory to fluoxetine, heavy menstrual bleeding with irregular cycles and new facial/neck hirsutism, and obesity (BMI 30.1)?
How should persistent facial tics be managed in a 12‑year‑old with Tourette’s syndrome after discontinuing escitalopram (Lexapro) and atomoxetine (Strattera)?
Is sertraline 50 mg safe for blood pressure and does it cause hypotension?
What are the typical initial presenting symptoms of Tourette syndrome in children, including early motor and vocal tics?
Please generate a SOAP note with CPT and ICD‑10 codes for a 41‑year‑old male presenting with a left forearm and elbow injury sustained four days ago while moving a hot tub, currently in a sling, experiencing pain and limited rotation, with a history of type 2 diabetes mellitus and hypertension, no drug allergies, and requiring radiographs and MRI.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.